AllianceBernstein
TYRA icon

AllianceBernstein’s Tyra Biosciences TYRA Stock Holding History

AllianceBernstein’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
48,420
+16,430
+51% +$544K ﹤0.01% 2082
2026
Q1 		$841K Hold
31,990
– – ﹤0.01% 2412
2025
Q4 		$841K Sell
31,990
-1,270
-4% -$23.3K ﹤0.01% 2425
2025
Q3 		$465K Sell
33,260
-2,380
-7% -$27.1K ﹤0.01% 2717
2025
Q2 		$341K Buy
35,640
+18,070
+103% +$172K ﹤0.01% 2852
2025
Q1 		$163K Hold
17,570
– – ﹤0.01% 2973
2024
Q4 		$244K Hold
17,570
– – ﹤0.01% 2968
2024
Q3 		$413K Hold
17,570
– – ﹤0.01% 2758
2024
Q2 		$281K Buy
+17,570
New +$302K ﹤0.01% 2939

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

AllianceBernstein's TYRA Position: Q2 2026 in Review

AllianceBernstein increased its Tyra Biosciences (TYRA) stake by 51% in Q2 2026, buying an estimated $544K and bringing the position to 48,420 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2082.

AllianceBernstein first reported a position in TYRA in Q2 2024 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • AllianceBernstein held 48,420 shares of Tyra Biosciences worth $1.85M as of Q2 2026.
  • AllianceBernstein bought 16,430 Tyra Biosciences shares in Q2 2026, an estimated $544K.
  • Tyra Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2082 holding.
  • AllianceBernstein first reported a position in Tyra Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.